| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |